fda bpc-157 not approved for human use warning unapproved peptide safety risks new drug The FDA has issued clear signals BPC-157: Experimental Peptide Creates Risk

Is the selected listing in stock, low stock, pre-order, or out of stock

It is classified and sold in the United States as a research-use-only (RUO) material

E-Posters - DIGITAL TRANSFORMATION, AI AND ROBOTICS 07.00 - DIGITAL TRANSFORMATION, AI AND ROBOTICS - 07.01 - TECHNOLOGY INNOVATIONS: ROBOTS, VIRTUAL REALITY, ARTIFICIAL INTELLIGENCE AND MORE P2599 - ESOC25-1676 APPLICATION OF AI TO MONITOR AND IMPROVE QUALITY OF LIFE IN THE POST-STROKE PERIOD Javokhir Abdullaev 1 , Makhsudjan Ataniyazov 1 1 Tashkent Medical Academy, The Department of Neurology and Medical Psychology, Tashkent, Uzbekistan Background and Aims: To study the possibilities and effectiveness of using artificial intelligence (AI) technologies for monitoring health status, predicting rehabilitation potential and developing personalized approaches to improving the quality of life of patients in the post-stroke period

Lyophilized Stability: Freeze-dried format enhances shelf life and stability

Alcohol Education: Must attend an alcohol education program of three months or longer (if the driver is at least 18 years old)